Supportive evidences on the decrease of gelsolin levels have been reported in acute injury and inflammation such as ischemic stroke, rheumatoid arthritis, chronic kidney disease, and infectious diseases (Peddada et al., 2012[29]). This evidence concerns the gene GSN and chronic kidney disease.